Immunomodulation by curcumin

Advances in Experimental Medicine and Biology

Volumn 595, Issue , 2007, Pages 321-341

  Gautam, Subhash C ^a   Gao, Xiaohua ^a   Dulchavsky, Scott ^a  

^a HENRY FORD HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; CELL CYCLE PROTEIN; CURCUMIN; CURCUMINATE SODIUM; CYCLOSPORIN; CYTOKINE; DIACETYLCURCUMIN; HERBACEOUS AGENT; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; JANUS KINASE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PHENYLBUTAZONE; QUERCETIN; STAT PROTEIN; TETRAHYDROCURCUMIN; TRANSCRIPTION FACTOR; TRIETHYLCURCUMIN; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; UNCLASSIFIED DRUG;

ACUTE GRAFT REJECTION; ADJUVANT ARTHRITIS; ANOREXIA; ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; CELL POPULATION; CELLULAR IMMUNITY; CHINESE MEDICINE; CLINICAL TRIAL; CURCUMA LONGA; CURCUMA XANTHORRHIZA; CYTOKINE PRODUCTION; CYTOTOXIC T LYMPHOCYTE; DRUG POTENTIATION; EDEMA; GENE EXPRESSION REGULATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMORAL IMMUNITY; IMMUNOMODULATION; INFLAMMATORY DISEASE; IRIDOCYCLITIS; JAUNDICE; KIDNEY ISCHEMIA; LIVER DISEASE; LYMPHOCYTE PROLIFERATION; LYMPHOID CELL; MEDICINAL PLANT; MENSTRUAL IRREGULARITY; NEOPLASM; NEUROTOXICITY; NONHUMAN; ORBIT PSEUDOTUMOR; POSTOPERATIVE EDEMA; POSTOPERATIVE PAIN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REPERFUSION INJURY; REVIEW; RHEUMATIC DISEASE; RHEUMATOID ARTHRITIS; WOUND;

CURCUMA LONGA;

EID: 84934444824     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-0-387-46401-5_14     Document Type: Review

References (74)

1. R. C. Srimal and B. N. Dhawan, Pharmacology of diferuloyl methane (curcumin), a non-steroidal anti-inflammatory agent. J Pharm Pharmacol 25, 447-452 (1973).
2. A. Mukhopadhyay, N. Basu, N. Ghatak, and P. K. Gujral, Matory and irritant activities of curcumin. Agents Actions 12, 508-515 (1982).
3. M. T Huang, T. Lysz, T. Ferraro, T. F. Abidi, J. D. Laskin, and A. H. Conney, Inhibitory effects of curcumin on in vitro lipoxygenase and cyclooxygenase activities in mouse epidermis. Cancer Res 51, 813-819 (1991).
4. S. D. Deodhar, R. Sethi, and R. C. Srimal, Preliminary study on antirheumatic activity of curcumin (diferuloyl methane). Indian J Med Res 71, 632-634 (1980).
5. R. R. Satoskar, S. J. Shah, and S. G. Shenoy, Evaluation of anti-inflammatory property of curcumin (diferuloyl methane) in patients with postoperative inflammation. Int J Pharmacol Ther Toxicol 24, 651-654 (1986).
6. B. Lal, A. K. Kapoor, O. P. Asthana, P. K. Agrawal, R. Prasad, and P. Kumar, Efficacy of curcumin in the management of chronic anterior uveitis. Phytother Res 13, 318-322 (1999).
7. B. Lal, A. K. Kapoor , O. P. Asthana, and R. C. Srimal, Role of curcumin in idiopathic inflammatory orbital pseudotumours. Phytother Res 14, 443-447 (2000).
8. J. Hong, M. Bose, J. Ju, J. H. Ryu, X. Chen, S. Sang, M. J. Lee, , and C. S. Yang, Modulation of arachidonic acid metabolism by curcumin and related beta-diketone derivatives: Effects on cytosolic phospholipase A(2), cyclooxygenases and 5-lipoxygenase. Carcinogenesis 25, 1671 (2004).
9. F. Zhang, N. K. Altorki, J. R. Mestre, K.Subbaramaiah, and A. J. Dannenberg, Curcumin inhibits cyclooxygenase-2 transcription in bile acid- and phorbol ester-treated human gastrointestinal epithelial cells. Carcinogenesis 20, 445 (1999).
10. A. Goel, C. R. Boland, and D. P. Chauhan, Specific inhibition of cyclooxygenase-2 (COX-2) expression by dietary curcumin in HT-29 human colon cancer cells. Cancer Lett 172, 111-118 (2001).
11. K. S. Chun, Y. S. Keum, S. S. Han, Y. S. Song, S. H. Kim, and Y. J. Surh, Curcumin inhibits phorbol ester-induced expression of cyclooxygenase-2 in mouse skin through suppression of extracellular signal-regulated kinase activity and NF-kappaB activation. Carcinogenesis 24, 1515 (2003).
12. D. L. Flynn, M. F. Rafferty, and A. M. Boctor, Inhibition of human neutrophil 5-lipooxygenase activity by gingerdione, shogaol, capsaicin and related pungent compounds. Prostaglandins Leukot Med 24, 195-198 (1986).
13. G. Y. Kim, K. H. Kim, S. H. Lee, M. S. Yoon, H. J. Lee, D. O. Moon, C. M. Lee, S. C. Ahn, Y. C. Park, and Y. M. Park, Curcumin inhibits immunostimulatory function of dendritic cells: MAPKs and translocation of NF-kappa B as potential targets. J Immunol 174, 8116 (2005).
14. S. Bhaumik, M. D. Jyothi, and A. Khar, Differential modulation of nitric oxide production by curcumin in host macrophages and NK cells. FEBS Lett 483, 78-82 (2000).
15. I. Brouet and H. Ohshima, Curcumin, an anti-tumour promoter and anti-inflammatory agent, inhibits induction of nitric oxide synthase in activated macrophages. Biochem Biophys Res Commun 206, 533-540 (1995).
16. S. Antony, R. Kuttan, and G. Kuttan, Immunomodulatory activity of curcumin. Immunol Invest 28, 291 (1999).
17. S. Yasni, K. Yoshiie, H. Oda, M. Sugano, and K. Imaizumi, Dietary Curcuma xanthorrhiza Roxb. increases mitogenic responses of splenic lymphocytes in rats, and alters populations of the lymphocytes in mice. J Nutr Sci Vitaminol (Tokyo) 39, 345 (1993).
18. M. Churchill, A. Chadburn, R. T. Bilinski, and M. M. Bertagnolli, Inhibition of intestinal tumors by curcumin is associated with changes in the intestinal immune cell profile. J Surg Res 89, 169 (2000).
19. S. Pal, S. Bhattacharyya, T. Choudhuri, G. K. Datta, T. Das, and G. Sa, Amelioration of immune cell number depletion and potentiation of depressed detoxification system of tumor-bearing mice by curcumin. Cancer Detect Prev 29, 470 (2005).
20. J. S. James, Curcumin: Clinical trial finds no antiviral effect. AIDS Treat News 242, 1 (1996).
21. X. Li X. Liu, Effect of curcumin on immune function of mice. J Huazhong Univ Sci Technolog Med Sci 25, 137 (2005).
22. G. M. Cole, T. Morihara, G. P. Lim, F. Yang, A. Begum, and S. A. Frautschy, NSAID and antioxidant prevention of Alzheimer's disease: Lessons from in vitro and animal models. Ann NY Acad Sci 1035, 68 (2004).
23. W. Lukita-Atmadja, Y. Ito, G. L. Baker, and R. S. McCuskey, Effect of curcuminoids as anti-inflammatory agents on the hepatic microvascular response to endotoxin. Shock 17, 399 (2002).
24. H. Steller, Mechanisms and genes of cellular suicide. Science 267, 1445 (1995).
25. M. W. Mayo and A. S. Baldwin, The transcription factor NF-κB: control of oncogenesis and cancer therapy resistance. Biochim Biophys Acta 1470, M55-M62 (2000).
26. A. C. Bharti, N. Donato, S. Singh, and B. B. Aggarwal, Curcumin (diferuloylmethane) down-regulates the constitutive activation of nuclear factor-kB and IkBa kinase in human multiple myeloma cells, leading to suppression of proliferation and induction of apoptosis. Blood 101, 1053 (2003).
27. S. Uddin, A. R. Hussain, P. S. Manogaran, K. Al-Hussein, L. C. Platanias, M. I. Gutierrez, and K. G. Bhatia, Curcumin suppresses growth and induces apoptosis in primary effusion lymphoma. Oncogene 24, 7022 (2005).
28. T. Choudhuri, S. Pal, M. L. Agwarwal, T. Das, and G. Sa, Curcumin induces apoptosis in human breast cancer cells through p53-dependent Bax induction. FEBS Lett 512, 334 (2002).
29. L. Li, B. B. Aggarwal, S. Shishodia, J. Abbruzzese, and R. Kurzrock, Nuclear factor-kappaB and IkappaB kinase are constitutively active in human pancreatic cells, and their down-regulation by curcumin (diferuloylmethane) is associated with the suppression of proliferation and the induction of apoptosis. Cancer 101, 2351 (2004).
30. P. G. Radhakrishna, A. S.Srivastava, T. I. Hassanein, D. P. Chauhan, and E. Carrier, Induction of apoptosis in human lung cancer cells by curcumin. Cancer Lett 208, 163 (2004).
31. T. Dorai, Y.-C. Cao, B. Dorai, R. Buttyan, and A. E. Katz, Therapeutic potential of curcumin in human prostate cancer. III. Curcumin inhibits proliferation, induces apoptosis, and inhibits angiogenesis of PC3 prostate cancer cells in vivo. Prostate 47, 293 (2001).
32. M. Zheng, S. Ekmekcioglu, E. T. Walch, C. H. Tang, and E. A. Grimm, Inhibition of nuclear factor-kappaB and nitric oxide by curcumin induces G2/M cell cycle arrest and apoptosis in human melanoma cells. Melanoma Res 14, 165 (2004).
33. L. Moragoda, R. Jaszewski, and A. P. Majumdar, Curcumin induced modulation of cell cycle and apoptosis in gastric and colon cancer cell lines. Oncogene 20, 7597 (2001).
34. A. S. Jaiswal, B. P. Marlow, N. Gupta, and S. Narayan, Beta-catenin-mediated transactivation and cell-cell adhesion pathways are important in curcumin (diferuylmethane)-induced growth arrest and apoptosis in colon cancer cells. Oncogene 21, 8414 (2002).
35. A. Mukhopadhyaya, C. Bueso-Ramos, D. Chatterjee, P. Pantazis, and B. Aggarwal, Curcumin downregulates cell survival mechanisms in human prostate cancer cell lines. Oncogene 20, 759 (2001).
36. R. J. Anto, A. Mukhopadadhyay, K. Denning, and B. B. Aggarwal, Curcumin (diferuloylmethane) induces apoptosis through activation of caspase-8, BID cleavage and cytochrome c release: its suppression by ectopic expression of Bcl-2 and Bcl-xL. Carcinogenesis 23, 143 (2002).
37. S. Aggarwal, H. Ichikawa, Y. Takada, S. K. Sandur, S. Shishodia, and B. B. Aggarwal, Curcumin (diferuloylmethane) down-regulates expression of cell proliferation and antiapoptotic and metastatic gene products through suppression of IkappaBalpha kinase and Akt activation. Mol Pharmacol 69, 195 (2006).
38. J. Rajasingh, H. P. Raikwar, G. Muthian, C. Johnson, and J. J. Bright, Curcumin induces growth-arrest and apoptosis in association with the inhibition of constitutively active JAK-STAT pathway in T cell leukemia. Biochem Biophys Res Commun 340, 359 (2006).
39. M. S. Squires, E. A. Hudson, L. Howells, S. Sale, C. E. Houghton, J. L. Jones, L. H. Fox, M. Dickens, S. A. Prigent, and M. M.. Manson, Relevance of mitogen activated protein kinase (MAPK) and phosphotidylinositol-3-kinase/ protein kinase B (PI3K/PKB) pathways to induction of apoptosis by curcumin in breast cells. Biochem Pharmacol 65, 361 (2003).
40. J. A. Bush, K. J. Cheung, Jr., and G. Li, Curcumin induces apoptosis in human melanoma cells through a Fas receptor/caspase-8 pathway independent of p53. Exp Cell Res 271, 305 (2001).
41. B. B. Aggarwal, S. Shishodia, Y. Takada, S. Banerjee, R. A. Newman, C. E. Bueso-Ramos, and J. E. Price, Curcumin suppresses the paclitaxel-induced nuclear factor-kappaB pathway in breast cancer cells and inhibits lung metastasis of human breast cancer in nude mice. Clin Cancer Res 11, 7490 (2005).
42. T.-C.Hour, J. Chen, J., Huang, J.-Y. Guan, S.-H. Lu, and Y.-S. Pu, Curcumin enhances cytotoxicity of chemotherapeutic agents in prostate cancer cells by inducing p21WAFI/CIPI and C/EBPβ expressions and suppressing NF-kB activation. Prostate 51, 211 (2002).
43. D. Deeb, H. Jiang, X. Gao, M. S. Hafner, H. Wong, G. Divine, R. A. Chapman, S. A. Dulchavsky, and S. C. Gautam, Curcumin sensitizes prostate cancer cells to tumor necrosis factor-related apoptosis-inducing ligand/Apo2L by inhibiting nuclear factor-kappaB through suppression of IkappaBalpha phosphorylation. Mol Cancer Ther 3, 803 (2004).
44. D. Deeb, Y. X. Xu, H. Jiang, X. Gao, N. Janakiraman, R. A. Chapman, and S. C. Gautam, Curcumin (diferuloyl-methane) enhances tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in LNCaP prostate cancer cells. Mol Cancer Ther 2, 95 (2003).
45. D. D. Deeb, H. Jiang, X. Gao, G. Divine, S. A. Dulchavsky, and S. C. Gautam, Chemosensitization of hormone-refractory prostate cancer cells by curcumin to TRAIL-induced apoptosis. J Exp Ther Oncol 5, 81 (2005).
46. X. Gao, D. Deeb, H. Jiang, Y. B. Liu, S.A. Dulchavsky, and S. C. Gautam, Curcumin differentially sensitizes malignant glioma cells to TRAIL/Apo2L-mediated apoptosis through activation of procaspases and release of cytochrome c from mitochondria. J Exp Ther Oncol 5, 39 (2005).
47. E. M. Jung, J. H. Lim, JT. J. Lee, J. W. Park, K. S. Choi, and T. K. Kwon, Curcumin sensitizes tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis through reactive oxygen species-mediated upregulation of death receptor 5 (DR5). Carcinogenesis 26, 1905 (2005).
48. Y. Kuramoto, K. Yamada, O. Tsuruta, and M. Sugano, Effect of natural food colorings on immunoglobulin production in vitro by rat spleen lymphocytes. Biosci Biotechnol Biochem 60, 1712 (1996).
49. E. H. South, J. H. Exon, and K. Hendrix, Dietary curcumin enhances antibody response in rats. Immunopharmacol Immunotoxicol 19, 105 (1997).
50. J. Odot, P. Albert, A. Carlier, M. Tarpin, J. Devy, and C. Madoulet, In vitro and in vivo anti-tumoral effect of curcumin against melanoma cells. Int J Cancer 111, 381 (2004).
51. X. Gao, J. Kuo, H. Jiang, D. Deeb, Y. Liu, G. Divine, R. A. Chapman, S. A. Dulchavsky, and S. C. Gautam, Immunomodulatory activity of curcumin: Suppression of lymphocyte proliferation, development of cell-mediated cytotoxicity, and cytokine production in vitro. Biochem Pharmacol 68, 51 (2004).
52. B. Cipriani, G. Borsellino, H. Knowles, D. Tramonti, F. Cavaliere, G. Bernardi, L. Battistini, and C. F. Brosnan, Curcumin inhibits activation of Vgamma9Vdelta2 T cells by phosphoantigens and induces apoptosis involving apoptosis-inducing factor and large scale DNA fragmentation. J Immunol 167, 3454 (2001).
53. D. Ranjan, C. Chen, T. D. Johnston, H. Jeon, and M. Nagabhushan, Curcumin inhibits mitogen stimulated lymphocyte proliferation, NFkappaB activation, and IL-2 signaling. J Surg Res 121, 171 (2004).
54. D. A. Shoskes, Effect of bioflavonoids quercetin and curcumin on ischemic renal injury: A new class of renoprotective agents. Transplantation 66, 147 (1998).
55. D. A. Shoskes, E. A. Jones, and A. Shahed, Synergy of mycophenolate mofetil and bioflavonoids in prevention of immune and ischemic injury. Transplant Proc 32, 798 (2000).
56. D. Shoskes, C. Lapierre, M. Cruz-Corerra, N. Muruve, R. Rosario, B. Fromkin, M. Braun, and J. Copley, Beneficial effects of bioflavonoids curcumin and quercetin on early function in cadaveric renal transplantation: A randomized placebo controlled trial. Transplantation 80, 1556 (2005).
57. S. C. Chueh, M. K. Lai, I. S. Liu, F. C. Teng, and J. Chen, Curcumin enhances the immunosuppressive activity of cyclosporine in rat cardiac allografts and in mixed lymphocyte reactions. Transplant Proc 35, 1603 (2003).
58. V. S. Yadav, K. P. Mishra, D. P. Singh, S. Mehrotra, and V. K. Singh, Immunomodulatory effects of curcumin. Immunopharmacol Immunotoxicol 27, 485 (2005).
59. M. M.-Y. Chan, Inhibition of tumor necrosis factor by curcumin, a phytochemical. Biochem Pharmacol 49, 1551 (1995).
60. B. Y. Kang, S. W. Chung, W. Chung, S. Im, S. Y. Hwang, and T. S. Kim, Inhibition of interleukin-12 production in lipopolysaccharide-activated macrophages by curcumin. Eur J Pharmacol 384, 191 (1999).
61. A. Literat, F. Su, M. Norwicki, M. Durand, R. Ramanathan, C. A. Jones, P. Minoo, and K. Y. Kwong, Regulation of pro-inflammatory cytokine expression by curcumin in hyaline membrane disease (HMD). Life Sci 70, 253 (2001).
62. T. Kobayashi, S. Hashomoto, and T. Horie, Curcumin inhibition of Dermatophagoides farinea-induced interleukin-5 (IL-5) and granulocyte macrophage-colony stimulating factor (GM-CSF) production by lymphocytes from bronchial asthmatics. Biochem Pharmacol 54, 819 (1997).
63. J. P. Gaddipati, S. V. Sundar, J. Calemine, P. Seth, G. S. Sidhu, and R. K. Maheshwari, Differential regulation of cytokines and transcription factors in liver by curcumin following hemorrhage/resuscitation. Shock 19, 150 (2003).
64. C. Natarajan and J. J. Bright, Curcumin inhibits experimental allergic encephalomyelitis by blocking IL-12 signaling through Janus kinase-STAT pathway in T lymphocytes. J Immunol 168, 6506 (2002).
65. Y. X. Xu, K. R. Pindolia, N. Janakiraman, C. J. Noth, R. A. Chapman, and S. C. Gautam, Curcumin, a compound with anti-inflammatory and anti-oxidant properties, down-regulates chemokine expression in bone marrow stromal cells. Exp Hematol 25(5), 413 (1997).
66. Y. Abe, S. Hashimoto, and T. Horie, Curcumin inhibition of inflammatory cytokine production by human peripheral blood monocytes and alveolar macrophages. Pharmacol Res 39, 41 (1999).
67. H. Hidaka, T. Ishiko, T. Furuhashi, H. Kamohara, S. Suzuki, M. Miyazaki, O. Ikeda, S. Mita, T. Setoguchi, and M. Ogawa, Curcumin inhibits interleukin 8 production and enhances interleukin 8 receptor expression on the cell surface: Impact on human pancreatic carcinoma cell growth by autocrine regulation. Cancer 95, 1206 (2002).
68. S. Ghosh, Regulation of inducible gene expression by the transcription factor NF-kappaB. Immunol Res 19, 183 (1999).
69. M. Karin, How NF-kB is activated: The role of the IkB kinase (IKK) complex? Oncogene 18, 6867 (1999).
70. S. Singh and B. B. Aggarwal, Activation of transcription factor NF-kappa B is suppressed by curcumin (diferuloylmethane). J Biol Chem 270, 24,995 (1995).
71. Y. X. Xu, K. R. Pindolia, N. Janakiraman, R. A. Chapman, and S. C. Gautam, Curcumin inhibits IL1 alpha and TNF-alpha induction of AP-1 and NF-kB DNA-binding activity in bone marrow stromal cells. Hematopathol Mol Hematol 11, 49 (1997).
72. C. Jobin, C. A. Bradham, M. P. Russo, B. Juma, A. S. Narula, D A. Brenner, and R. B. Sartor, Curcumin blocks cytokine-mediated NF-kappa B activation and proinflammatory gene expression by inhibiting inhibitory factor I-kappa B kinase activity. J Immunol 163, 3474 (1999).
73. B. Y. Kang, Y. J. Song, K. M. Kim, Y. K. Choe, S. Y. Hwang, and T. S. Kim, Curcumin inhibits Th1 cytokine profile in CD4+ T cells by suppressing interleukin-12 production in macrophages. Br J Pharmacol 128, 380 (1999).
74. S. M. Plummer, K. A. Holloway, M. M. Manson, R. J. Munks, A. Kaptein, S. Farrow, and L. Howells, Inhibition of cyclo-oxygenase 2 expression in colon cells by the chemopreventive agent curcumin involves inhibition of NF-kappaB activation via the NIK/IKK signalling complex. Oncogene 18, 6013 (1999).